New Hire – Chris Roberts – Vice President of Strategic Initiatives

We are pleased to announce that Chris Roberts will be joining #teamgravity as our Vice President of Strategic Initiatives. In this role, Chris will report directly to Tony Remington, Co-Founder & CEO, and be responsible for compliantly increasing testing volumes through strategic programming and partnerships. He will administer and manage growth-focused projects in collaboration with…

Read More

UK St. Claire and Gravity Diagnostics to Enhance Substance Use Disorder Recovery with Advanced Toxicology Diagnostic Services

Morehead, KY – [12/19/24] – UK St. Claire will contract with Gravity Diagnostics for comprehensive and compliant toxicology diagnostic services to patients. After a competitive and selective bidding process, Gravity Diagnostics was selected to work with UK St. Claire to further strengthen efforts to support substance use disorder (SUD) recovery across the region. UK St.…

Read More

Kentucky Biomarker Bill: The Right Test for the Right Treatment

Author: Dr. JP Canner, Ph.D., NRCC, MT(AAB) The right test for the right treatment.    The Commonwealth of Kentucky enacted HB180 this year which mandates insurance coverage of biomarker testing.  Kentucky joins 13 other states with legislation addressing this complex issue.   Biomarkers can either be direct targets or closely associated indicators of a disease. …

Read More

PGx: Truth, Hope, and Hype

Author: Dr. JP Canner, Ph.D., NRCC, MT(AAB) Pharmacogenetics (PGx) is the practice of applying the knowledge of an individual’s genes to guide the best therapeutic options.  Given the generality of this definition, there are numerous ways to implement PGx in practice.  In this article, we’ll cover the basics of PGx, detailing what it is and…

Read More

Gravity Diagnostics Expands Testing Services to Include Xylazine Detection: A Crucial Advancement in Ensuring Public Safety

  [[Covington, KY] – [9/20/23] – Gravity Diagnostics, a leading clinical toxicology laboratory, is announcing a significant expansion of their testing services. They are now offering comprehensive testing for Xylazine, a powerful sedative and muscle relaxant. This groundbreaking addition to their testing portfolio demonstrates their unwavering commitment to advancing public health and safety. Xylazine, originally…

Read More

Gravity Diagnostics Receives $20 Million Line of Credit from PNC Bank to Support COVID-19 Testing

COVINGTON, Ky., Jan. 12, 2021 /PRNewswire/ — Gravity Diagnostics has announced that PNC Bank has authorized a $20 million line of credit to the diagnostics laboratory to support investments in inventory, equipment, and operations to increase its capacity and capabilities. Gravity Diagnostics is a full-service CLIA laboratory licensed in all 50 states providing laboratory testing in the areas of COVID-19,…

Read More